Literature DB >> 1670934

Adherence of Bacteroides fragilis group species.

I Brook1, M L Myhal.   

Abstract

The ability of piliated and capsulated Bacteroides fragilis and Bacteroides ovatus to adhere to intestinal cells and mucus was investigated. The adherence of piliated and capsulated strains was at least five times greater than the adherence of their nonpiliated and noncapsulated or capsulated only counterparts. These data illustrate the importance of pili as promoters of adherence of B. fragilis group species to the gastrointestinal mucosa.

Entities:  

Mesh:

Year:  1991        PMID: 1670934      PMCID: PMC257825          DOI: 10.1128/iai.59.2.742-744.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Divergent effects of cyclic adenosine 3',5'-monophosphate on formation of type 1 fimbriae in different K-12 strains of Escherichia coli.

Authors:  B I Eisenstein; E H Beachey; S S Solomon
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

3.  Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine.

Authors:  I Ofek; A Mosek; N Sharon
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Pathogenicity of piliated and encapsulated Bacteroides fragilis.

Authors:  I Brook; J C Coolbaugh; R I Walker
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

5.  Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B. ruminicola subsp. brevis in abscesses in mice.

Authors:  I Brook; J D Gillmore; J C Coolbaugh; R I Walker
Journal:  J Infect       Date:  1983-11       Impact factor: 6.072

6.  Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections.

Authors:  I Brook; R I Walker
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains.

Authors:  C Pruzzo; B Dainelli; M Ricchetti
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Adherence of Bacteroides fragilis in vivo.

Authors:  A B Onderdonk; N E Moon; D L Kasper; J G Bartlett
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Microbial flora of the mouse ileum mucous layer and epithelial surface.

Authors:  K R Rozee; D Cooper; K Lam; J W Costerton
Journal:  Appl Environ Microbiol       Date:  1982-06       Impact factor: 4.792

Review 10.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

View more
  4 in total

Review 1.  Evolutionary and ecological forces that shape the bacterial communities of the human gut.

Authors:  J S Messer; E R Liechty; O A Vogel; E B Chang
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

2.  Vaginal carriage of enterotoxigenic Bacteroides fragilis in pregnant women.

Authors:  P Leszczynski; A van Belkum; H Pituch; H Verbrugh; F Meisel-Mikolajczyk
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 3.  Bacteroides: the good, the bad, and the nitty-gritty.

Authors:  Hannah M Wexler
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 4.  A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue.

Authors:  Christina Westermann; Marita Gleinser; Sinéad C Corr; Christian U Riedel
Journal:  Front Microbiol       Date:  2016-08-05       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.